170 related articles for article (PubMed ID: 38481281)
21. A multifunctional nanodiamond-based nanoplatform for the enhanced mild-temperature photothermal/chemo combination therapy of triple negative breast cancer via an autophagy regulation strategy.
Cui X; Liang Z; Lu J; Wang X; Jia F; Hu Q; Xiao X; Deng X; Wu Y; Sheng W
Nanoscale; 2021 Aug; 13(31):13375-13389. PubMed ID: 34477743
[TBL] [Abstract][Full Text] [Related]
22. Targeted polydopamine nanoparticles enable photoacoustic imaging guided chemo-photothermal synergistic therapy of tumor.
Li Y; Jiang C; Zhang D; Wang Y; Ren X; Ai K; Chen X; Lu L
Acta Biomater; 2017 Jan; 47():124-134. PubMed ID: 27721008
[TBL] [Abstract][Full Text] [Related]
23. Hyaluronic acid-coated PEI-PLGA nanoparticles mediated co-delivery of doxorubicin and miR-542-3p for triple negative breast cancer therapy.
Wang S; Zhang J; Wang Y; Chen M
Nanomedicine; 2016 Feb; 12(2):411-20. PubMed ID: 26711968
[TBL] [Abstract][Full Text] [Related]
24. Folate-receptor-targeted laser-activable poly(lactide-
Liu F; Chen Y; Li Y; Guo Y; Cao Y; Li P; Wang Z; Gong Y; Ran H
Int J Nanomedicine; 2018; 13():5139-5158. PubMed ID: 30233177
[TBL] [Abstract][Full Text] [Related]
25. Multi-Enzyme Cascade-Triggered Nitric Oxide Release Nanoplatform Combined with Chemo Starvation-like Therapy for Multidrug-Resistant Cancers.
Li G; Lu X; Zhang S; Zhang J; Fu X; Zhang M; Teng L; Sun F
ACS Appl Mater Interfaces; 2023 Jul; 15(26):31285-31299. PubMed ID: 37344958
[TBL] [Abstract][Full Text] [Related]
26. Multifunctional Nanoparticles Codelivering Doxorubicin and Amorphous Calcium Carbonate Preloaded with Indocyanine Green for Enhanced Chemo-Photothermal Cancer Therapy.
Yu J; Wang L; Xie X; Zhu W; Lei Z; Lv L; Yu H; Xu J; Ren J
Int J Nanomedicine; 2023; 18():323-337. PubMed ID: 36700147
[TBL] [Abstract][Full Text] [Related]
27. Nitric oxide-releasing nanoparticles improve doxorubicin anticancer activity.
Alimoradi H; Greish K; Barzegar-Fallah A; Alshaibani L; Pittalà V
Int J Nanomedicine; 2018; 13():7771-7787. PubMed ID: 30538458
[TBL] [Abstract][Full Text] [Related]
28. Targeted treatment of triple-negative-breast cancer through pH-triggered tumour associated macrophages using smart theranostic nanoformulations.
Scialla S; Hanafy MS; Wang JL; Genicio N; Costa Da Silva M; Costa M; Oliveira-Pinto S; Baltazar F; Gallo J; Cui Z; Bañobre-López M
Int J Pharm; 2023 Feb; 632():122575. PubMed ID: 36603672
[TBL] [Abstract][Full Text] [Related]
29. A TME-activated nano-catalyst for triple synergistic therapy of colorectal cancer.
Liu Q; Xiang Y; Yu Q; Lv Q; Xiang Z
Sci Rep; 2024 Feb; 14(1):3328. PubMed ID: 38336997
[TBL] [Abstract][Full Text] [Related]
30. Tumor-targeted and multi-stimuli responsive drug delivery system for near-infrared light induced chemo-phototherapy and photoacoustic tomography.
Feng Q; Zhang Y; Zhang W; Shan X; Yuan Y; Zhang H; Hou L; Zhang Z
Acta Biomater; 2016 Jul; 38():129-42. PubMed ID: 27090593
[TBL] [Abstract][Full Text] [Related]
31. An iron oxide nanoparticle-based transdermal nanoplatform for dual-modal imaging-guided chemo-photothermal therapy of superficial tumors.
Zhang Y; Li F; Ya S; Hu Y; Zhi D; Wang W; Xu M; Qiu B; Ding W
Acta Biomater; 2021 Aug; 130():473-484. PubMed ID: 34082102
[TBL] [Abstract][Full Text] [Related]
32. Facile synthesis of near-infrared responsive on-demand oxygen releasing nanoplatform for precise MRI-guided theranostics of hypoxia-induced tumor chemoresistance and metastasis in triple negative breast cancer.
Zhang D; You Y; Xu Y; Cheng Q; Xiao Z; Chen T; Shi C; Luo L
J Nanobiotechnology; 2022 Mar; 20(1):104. PubMed ID: 35246149
[TBL] [Abstract][Full Text] [Related]
33. ROS-responsive Galactosylated-nanoparticles with Doxorubicin Entrapment for Triple Negative Breast Cancer Therapy.
Zhou J; Li K; Zang X; Xie Y; Song J; Chen X
Int J Nanomedicine; 2023; 18():1381-1397. PubMed ID: 36987427
[TBL] [Abstract][Full Text] [Related]
34. Remodeling of tumor microenvironment for enhanced tumor chemodynamic/photothermal/chemo-therapy.
Zhang Y; Zhu J; Zhang Z; He D; Zhu J; Chen Y; Zhang Y
J Nanobiotechnology; 2022 Aug; 20(1):388. PubMed ID: 36028817
[TBL] [Abstract][Full Text] [Related]
35. Dual-Stage Irradiation of Size-Switchable Albumin Nanocluster for Cascaded Tumor Enhanced Penetration and Photothermal Therapy.
He P; Lei Q; Yang B; Shang T; Shi J; Ouyang Q; Wang W; Xue L; Kong F; Li Z; Huang J; Liu L; Guo J; Brinker CJ; Liu K; Zhu W
ACS Nano; 2022 Sep; 16(9):13919-13932. PubMed ID: 36082976
[TBL] [Abstract][Full Text] [Related]
36. Near-infrared light switching nitric oxide nanoemitter for triple-combination therapy of multidrug resistant cancer.
Wei G; Yang G; Wei B; Wang Y; Zhou S
Acta Biomater; 2019 Dec; 100():365-377. PubMed ID: 31586724
[TBL] [Abstract][Full Text] [Related]
37. cRGD-Conjugated Fe
Fan X; Yuan Z; Shou C; Fan G; Wang H; Gao F; Rui Y; Xu K; Yin P
Int J Nanomedicine; 2019; 14():9631-9645. PubMed ID: 31824156
[TBL] [Abstract][Full Text] [Related]
38. Treatment of triple negative breast cancer by near infrared light triggered mild-temperature photothermal therapy combined with oxygen-independent cytotoxic free radicals.
Li R; Hu X; Shang F; Wu W; Zhang H; Wang Y; Pan J; Shi S; Dong C
Acta Biomater; 2022 Aug; 148():218-229. PubMed ID: 35705171
[TBL] [Abstract][Full Text] [Related]
39. NIR-II light triggered nitric oxide release nanoplatform combined chemo-photothermal therapy for overcoming multidrug resistant cancer.
Wang J; Wu C; Qin X; Huang Y; Zhang J; Chen T; Wang Y; Ding Y; Yao Y
J Mater Chem B; 2021 Feb; 9(6):1698-1706. PubMed ID: 33495772
[TBL] [Abstract][Full Text] [Related]
40. Folic Acid-Modified Erythrocyte Membrane Loading Dual Drug for Targeted and Chemo-Photothermal Synergistic Cancer Therapy.
Chen Z; Wang W; Li Y; Wei C; Zhong P; He D; Liu H; Wang P; Huang Z; Zhu W; Zhou Y; Qin L
Mol Pharm; 2021 Jan; 18(1):386-402. PubMed ID: 33296217
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
